Sökning: WFRF:(Kilander Anders) > Cystatin C Levels a...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05892naa a2200745 4500 | |
001 | oai:DiVA.org:uu-130132 | |
003 | SwePub | |
008 | 100901s2010 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:b7f47be6-82a7-4447-a117-ec91e2748646 | |
009 | oai:gup.ub.gu.se/126836 | |
009 | oai:prod.swepub.kib.ki.se:121272499 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1301322 URI |
024 | 7 | a https://doi.org/10.3233/JAD-2010-0915942 DOI |
024 | 7 | a https://lup.lub.lu.se/record/16973892 URI |
024 | 7 | a https://gup.ub.gu.se/publication/1268362 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1212724992 URI |
040 | a (SwePub)uud (SwePub)lud (SwePub)gud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Sundelöf, Johanu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)josun205 |
245 | 1 0 | a Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls |
264 | 1 | c 2010 |
338 | a print2 rdacarrier | |
520 | a Cystatin C is suggested to be involved in neurodegeneration and the development of Alzheimer's disease (AD) by binding to soluble amyloid-beta (Abeta) peptides. Studies of cystatin C levels in cerebrospinal fluid (CSF) in relation to risk of AD are conflicting and relations between cystatin C, Abeta42, and tau levels in CSF in AD, mild cognitive impairment (MCI), and healthy controls are unknown. The objective of this study was to investigate cystatin C, Abeta42, and tau levels in CSF in AD, MCI, and controls. As a secondary aim, the relationships between cystatin C, Abeta42, and tau levels across disease groups were investigated. Cystatin C, Abeta42, total tau, and phosphorylated tau levels in CSF were analyzed by turbidimetry (cystatin C) and xMAP Luminex technology (Abeta and tau) in persons with AD (n=101), MCI (n=84), and healthy control subjects (n=28). Mean cystatin C levels were similar in cases of AD (5.6 mumol/L +/- 1.7), MCI (5.4 mumol/L +/- 1.48), and controls (5.6 mumol/L +/- 1.6). However, CSF cystatin C levels were strongly and positively correlated with total tau and phosphorylated tau levels (r=0.61-0.81, p< 0.0001) and Abeta42 (r=0.35-0.65, p< 0.001) independent of age, gender, and APOE genotype. Mean CSF cystatin C levels did not differ between patients with AD and MCI and healthy controls. Interestingly, cystatin C levels were positively correlated with both tau and Abeta42 levels in CSF independent of age, gender, and APOE genotype. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Psykiatri0 (SwePub)302152 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Psychiatry0 (SwePub)302152 hsv//eng |
653 | a Alzheimer's disease | |
653 | a biomarkers | |
653 | a case control study | |
653 | a cystatin C | |
653 | a epidemiology | |
653 | a risk factor | |
653 | a MEDICINE | |
653 | a MEDICIN | |
653 | a epidemiology | |
653 | a cystatin C | |
653 | a case control study | |
653 | a Alzheimer's disease | |
653 | a biomarkers | |
653 | a risk factor | |
700 | 1 | a Sundstrom, Johanu Uppsala universitet,Institutionen för medicinska vetenskaper4 aut0 (Swepub:uu)johasund |
700 | 1 | a Hansson, Oskaru Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)mphy-ohn |
700 | 1 | a Eriksdotter-Jönhagen, Mariau Karolinska Institutet4 aut |
700 | 1 | a Giedraitis, Vilmantasu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)vigie517 |
700 | 1 | a Larsson, Andersu Uppsala universitet,Klinisk kemi4 aut0 (Swepub:uu)andlarss |
700 | 1 | a Degerman-Gunnarsson, Malinu Uppsala universitet,Geriatrik4 aut |
700 | 1 | a Ingelsson, Martinu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)maing121 |
700 | 1 | a Minthon, Lennartu Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)psyk-lmi |
700 | 1 | a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka |
700 | 1 | a Kilander, Lenau Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)lekil226 |
700 | 1 | a Basun, Hansu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)habas169 |
700 | 1 | a Lannfelt, Larsu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)lalan021 |
700 | 1 | a Luoto, Johannesu Lund University,Lunds universitet,Geriatrik,Forskargrupper vid Lunds universitet,Geriatric Medicine,Lund University Research Groups,Geriatrics4 aut0 (Swepub:lu)med-jst |
710 | 2 | a Uppsala universitetb Geriatrik4 org |
773 | 0 | t Journal of Alzheimer's Diseaseg 21:2, s. 471-478q 21:2<471-478x 1387-2877x 1875-8908 |
856 | 4 | u http://dx.doi.org/10.3233/JAD-2010-091594y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-130132 |
856 | 4 8 | u https://doi.org/10.3233/JAD-2010-091594 |
856 | 4 8 | u https://lup.lub.lu.se/record/1697389 |
856 | 4 8 | u https://gup.ub.gu.se/publication/126836 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:121272499 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.